Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study

Abstract Background Apolipoprotein-E (APOE) genetic testing for Alzheimer’s disease is becoming more important as clinical trials are increasingly targeting individuals carrying APOE-ε4 alleles. Little is known about the interest in finding out one’s genetic risk for Alzheimer’s disease in the gener...

Full description

Bibliographic Details
Main Authors: Lisa Waterink, Larissa A. Masselink, Sven J. van der Lee, Leonie N. C. Visser, Solange Cleutjens, Jetske van der Schaar, Argonde C. van Harten, Philip Scheltens, Sietske A. M. Sikkes, Wiesje M. van der Flier, Marissa D. Zwan
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
Genetic screening
APOE disclosure
Dementia risk
Recruitment
Research registry
Clinical trials
Online Access:https://doi.org/10.1186/s13195-023-01364-w

Internet

https://doi.org/10.1186/s13195-023-01364-w

Similar Items